酒精使用障碍对法国2008至2013年慢性丙型肝炎疾病负担的贡献:一项全国性回顾性队列研究
该研究追踪法国97,347例18至65岁慢性丙型肝炎患者至2013年12月,评估酒精使用障碍(AUDs)对肝相关并发症、肝移植及肝病死亡的贡献。28,101例(28.9%)合并AUDs者肝相关并发症(OR=7.19)、肝移植(OR=4.28)和肝病死亡(OR=6.20)的比值比最高;AUDs归因风险占肝相关并发症的71.8%、肝移植的67.4%和肝病死亡的68.8%。
要点
- 合并AUDs的慢性丙型肝炎患者肝相关并发症、肝移植和肝病死亡的比值比分别为7.19、4.28和6.20。
- AUDs归因风险占17,669例肝相关并发症的71.8%、1,599例肝移植的67.4%和6,677例肝病死亡的68.8%。
- 戒酒与肝相关并发症风险降低78%(95%CI 76%至80%)相关,酒精康复治疗与降低60%(95%CI 57%至63%)相关。
核心结论
- 在法国,2008至2013年间AUDs贡献了年轻和中年成人慢性HCV感染负担的三分之二以上。
研究设计与样本
- 全国性回顾性队列研究,追踪2008年1月时年龄18至65岁的97,347例法国HCV患者至院内死亡或2013年12月。
- 主要结局为肝相关并发症的频率,次要结局为肝移植频率及其他原因别死亡。
- 测量了校正比值比(OR)、AUDs的人群归因风险及与HCV传播相关的其他肝病进展辅因子。
主要发现
- 28,101例(28.9%)合并AUDs者肝相关并发症的OR=7.19(95%CI 6.90至7.50),肝移植OR=4.28(95%CI 3.80至4.82),肝病死亡OR=6.20(95%CI 5.85至6.58)。
- 酒精康复治疗与肝相关并发症降低60%(95%CI 57%至63%)相关,戒酒与降低78%(95%CI 76%至80%)相关。
- AUDs归因风险占17,669例肝相关并发症的71.8%(95%CI 66.0至76.8),占1,599例肝移植的67.4%(95%CI 61.6至72.4),占6,677例肝病死亡的68.8%(95%CI 63.4至73.5)。
- 观察期间肝移植数量保持稳定,肝病死亡数量增加,且合并AUDs者增加速度更快。
临床怎么用
- 作者认为,应将促进戒酒列为高优先级,以减轻慢性HCV感染负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatitis C virus (HCV) patients are at risk of alcohol use disorders (AUDs). We measured the contribution of AUDs on the burden of chronic HCV infection in French HCV patients. METHODS: The hospital trajectory of 97,347 French HCV patients aged 18-65 in January 2008 were tracked and followed until in-hospital death or December 2013. Primary outcome was the frequency of liver-related complications. Secondary outcomes were the frequency of liver transplantation and otherwise cause-specific mortality. Adjusted odds ratios (OR), population attributable risks of AUDs and other cofactors of liver disease progression associated with HCV transmission were measured. RESULTS: The 28,101 (28.9%) individuals with AUDs had the highest odds for liver-related complications (OR=7.19; 95% confidence interval [CI], 6.90 to 7.50), liver transplantation (OR=4.28; 95% CI, 3.80 to 4.82), and liver death (OR=6.20; 95% CI, 5.85 to 6.58). Alcohol rehabilitation and abstinence were associated with 60% (95% CI, 57% to 63%) and 78% (95% CI, 76% to 80%) reduction of liver-related complications, respectively. The attributable risk of AUDs was 71.8% (95% CI, 66.0 to 76.8) of 17,669 liver-related complications, 67.4% (95% CI, 61.6 to 72.4) of 1,599 liver transplantations, and 68.8% (95% CI, 63.4 to 73.5) of 6,677 liver deaths. The number of liver transplantations remained stable and the number of liver deaths increased, at a faster rate for individuals with AUDs, over the observational period. CONCLUSION: In France, AUDs contributed to more than two-thirds of the burden of chronic HCV infection in young and middle-aged adults over 2008-2013. LAY SUMMARY: This study tracked liver-related complications and mortality of all 97,347 young and middle-aged patients (18-65years old) discharged with chronic HCV infection from French hospitals over 2008-2013. About 30% patients were recorded with alcohol use disorders (AUDs) and had the highest odds for liver-related complications (i.e. decompensated cirrhosis and liver cancer). AUDs contributed to more than two-thirds of 1,599 liver transplantations and 6,677 liver deaths recorded in patients with chronic HCV infection over 2008-2013 in France. Alcohol rehabilitation and abstinence were associated with above a 50% risk reduction of liver-related complications. Promoting alcohol abstinence should receive high priority to reduce the burden of chronic HCV infection.
引用
- Schwarzinger M, Baillot S, Yazdanpanah Y, et al. Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study. J Hepatol. 2017. PMID: 28396173. doi:10.1016/j.jhep.2017.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。